9 results match your criteria: "Canada. jwoulfe@ottawahospital.on.ca[Affiliation]"

FUS-immunoreactive intranuclear inclusions in neurodegenerative disease.

Brain Pathol

May 2010

Cancer Therapeutics Group, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Neuronal intranuclear inclusions (NIIs) are a histopathological hallmark of several neurodegenerative disorders. However, the role played by NIIs in neurodegenerative pathogenesis remains enigmatic. Defining their molecular composition represents an important step in understanding the pathophysiology of these disorders.

View Article and Find Full Text PDF

Promyelocytic leukaemia-immunoreactive neuronal intranuclear rodlets in the human brain.

Neuropathol Appl Neurobiol

February 2007

Cancer Research Program, The Ottawa Health Research Institute, Ottawa, Ontario, Canada.

In a previous study, we demonstrated immunoreactivity of a subset of neuronal intranuclear rodlets (INRs) in the human substantia nigra for promyelocytic leukaemia (PML) protein, the signature protein of PML bodies. In the present study, we extend these observations and describe the ultrastructural features, immunohistochemical staining characteristics, and topographical pattern of distribution of PML-immunoreactive intranuclear rodlets (PML-INRs). Consistent with a purported role for PML bodies in nuclear proteolysis and/or transcriptional regulation, PML-INRs are immunoreactive for components of the ubiquitin-proteasome system, the transcriptional regulator CREB-binding protein, acetylated histone H4, and the eukaryotic translation initiation factor eIF4E.

View Article and Find Full Text PDF

Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress.

Neuropathol Appl Neurobiol

February 2007

Department of Pathology, The Ottawa Hospital, University of Ottawa, and Cancer Research Program, The Ottawa Health Research Institute, Ottawa, Canada.

Neurodegenerative diseases are characterized pathologically by the abnormal accumulation of pathogenic protein species within the cell. Several neurodegenerative diseases feature intranuclear protein aggregation in the form of intranuclear inclusion bodies. Studies of these intranuclear inclusions are providing important clues regarding the cellular pathophysiology of these diseases, as exemplified by recent progress in defining the genetic basis of a subset of frontotemporal dementia cases.

View Article and Find Full Text PDF

There is growing appreciation that the nucleus is organized into an array of discrete structural domains, each subserving a specific function. These functional nuclear bodies are to be distinguished from pathological intranuclear inclusions which have been described in a variety of neurodegenerative diseases. Marinesco bodies (MBs) are eosinophilic ubiquitinated intranuclear inclusions found in pigmented neurons of the human substantia nigra and locus coeruleus.

View Article and Find Full Text PDF

Neuronal intranuclear rodlets were described in normal brain over a century ago, but their functional significance and pathological relevance is unknown. Here, we show co-localization of tubulin and glucocorticoid receptor-like immunoreactivity in these intranuclear inclusions in human brain. In addition, we provide evidence for a massive reduction in their areal density in Alzheimer's disease brain, but not in another common neurodegenerative condition, dementia with Lewy bodies.

View Article and Find Full Text PDF

Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions.

Acta Neuropathol

July 2001

Department of Pathology, Ottawa Hospital, Ontario, Canada.

Dementia of motor neuron disease type (DMND) is a variety of frontotemporal dementia (FTD) which is pathologically defined by characteristic neuronal ubiquitinated, tau- and synuclein-negative intracytoplasmic inclusions. Many cases with this pathology, however, do not have motor neuron disease. In the present study, we document the presence of ubiquitinated neuronal intranuclear inclusions in a sub-population of cases of neuropathologically verified DMND.

View Article and Find Full Text PDF

Monoclonal antibodies against Epstein-Barr virus cross-react with alpha-synuclein in human brain.

Neurology

November 2000

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.

Using antibodies generated against the latent membrane protein 1 of Epstein-Barr virus, intense immunoreactivity of Lewy bodies (in PD and dementia with Lewy bodies) and glial cytoplasmic inclusions (in multiple system atrophy) was demonstrated. ELISA and Western blotting techniques confirmed that this immunolabeling was due to cross-reactivity of the antiviral antibody with alpha-synuclein, a neuronal protein implicated in the pathogenesis of PD. This example of cross-reactivity between Epstein-Barr virus and alpha-synuclein may bear implications for further elucidating infectious or autoimmune mechanisms in PD.

View Article and Find Full Text PDF

Class III beta-tubulin immunoreactive intranuclear inclusions in human ependymomas and gangliogliomas.

Acta Neuropathol

October 2000

Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.

We have observed intranuclear inclusion bodies immunoreactive for the cytoskeletal protein class III beta tubulin (C3betaT) in neurons and ependymal cells of post-mortem human brain. The relationship of these inclusions, detected by light microscopy, to the intranuclear rodlets described by the classical microscopists is unknown. The present study was conducted to determine whether these proteinaceous inclusions (C3betaT-NIIs) exist in the neoplastic counterparts of these cell types.

View Article and Find Full Text PDF